1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, March 2016 (p6)

Biological Therapy Analysis & Statistics, March 2016 (p6)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

151-180 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, a stem cell technology that improves the field of ...

  • Industries : Biological Therapy
HTG Molecular Diagnostics, Inc. (HTGM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

HTG Molecular Diagnostics, Inc. (HTGM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary HTG Molecular Diagnostics, Inc. (HTG) is a technology company that provides molecular technology solutions. The company offers products including HTG edge system, HTG edgeseq reagents, HTG edge ...

  • Industries : Biological Therapy, Diagnostics, Diagnostics
  • Countries : United States
Cell Therapy Catapult Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cell Therapy Catapult Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary Cell Therapy Catapult Limited (Catapult), d/b/a Cell and Gene Therapy Catapult, is a biotechnology company that develops, delivers and commercializes cell and gene therapies. The company helps ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation, Drug Delivery Technology, Biotechnology
California Institute for Regenerative Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

California Institute for Regenerative Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary California Institute for Regenerative Medicine (CIRM) is a medical research service provider that makes grants and offers loans for stem cell research, facilities and other opportunities. The organization ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
Antisense Therapeutics Limited (ANP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Antisense Therapeutics Limited (ANP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary Antisense Therapeutics Limited (ANP) is a biopharmaceutical company with focus on the discovery, development and commercialization of second generation antisense pharmaceuticals for large unmet ...

  • Industries : Therapy, Biological Therapy
Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2016
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications ...

  • Industries : Biological Therapy, Medical Equipment and Supply
HTG Molecular Diagnostics, Inc. (HTGM) - Medical Equipment - Deals and Alliances Profile

HTG Molecular Diagnostics, Inc. (HTGM) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2016
  • by Global Data

Summary HTG Molecular Diagnostics, Inc. (HTG) is a technology company that provides molecular technology solutions. The company offers products including HTG edge system, HTG edgeseq reagents, HTG edge ...

  • Industries : Biological Therapy, In Vitro Diagnostic, In Vitro Diagnostic, Diagnostics, Diagnostics
  • Countries : United States
Eckert & Ziegler BEBIG S.A. (EZBG) - Medical Equipment - Deals and Alliances Profile

Eckert & Ziegler BEBIG S.A. (EZBG) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2016
  • by Global Data

Summary Eckert & Ziegler BEBIG S.A. (Eckert & Ziegler) a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG is a medical device company that manufactures and provides radiotherapy and brachytherapy ...

  • Industries : Biological Therapy
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile

Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2016
  • by Global Data

Summary Interleukin Genetics, Inc. (Interleukin) is a molecular diagnostics company. It develops and distributes genetic tests for the personalized health market. Its major genetic tests include PerioPredict ...

  • Industries : Biological Therapy, General Medicine and Specialty Medicine
Antisense Therapeutics Limited

Antisense Therapeutics Limited

  • $ 99
  • Company report
  • April 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Antisense Therapeutics Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy, Hospitality, Hospitality, Biotechnology
  • Countries : United States, World
Ziopharm Oncology, Inc.

Ziopharm Oncology, Inc.

  • $ 99
  • Company report
  • April 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Ziopharm Oncology, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Biological Therapy, Pathology
  • Countries : United States, World
Japan Tissue Engineering Company Limited

Japan Tissue Engineering Company Limited

  • $ 99
  • Company report
  • April 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Japan Tissue Engineering Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biological Therapy, Genomics, Biotechnology, Hospitality, Hospitality
  • Countries : Japan
International Stem Cell Corporation

International Stem Cell Corporation

  • $ 99
  • Company report
  • March 2016
  • by Wright Investors' Service

A textual analysis of the financial results for International Stem Cell Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
China Regenerative Medicine International Ltd

China Regenerative Medicine International Ltd

  • $ 99
  • Company report
  • March 2016
  • by Wright Investors' Service

A textual analysis of the financial results for China Regenerative Medicine International Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biological Therapy, Genomics, Biotechnology, Hospitality, Hospitality
  • Countries : China
US Stem Cell Inc

US Stem Cell Inc

  • $ 99
  • Company report
  • March 2016
  • by Wright Investors' Service

A textual analysis of the financial results for US Stem Cell Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
  • Countries : United States
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

  • $ 4 995
  • Industry report
  • February 2016
  • by GBI Research

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence Summary Breast cancer, a malignant neoplasm, is the second-most ...

  • Industries : Pharmaceutical, Therapy
  • Countries : World, Asia
Biosimilars in Oncology: Update Bulletin [Feb 2016]

Biosimilars in Oncology: Update Bulletin [Feb 2016]

  • $ 1 040
  • Industry report
  • February 2016
  • by Firstword Pharma

New KOL insights on the latest events that have the potential to shape the oncology biosimilars market. Topics covered include opinions about data from Sandoz’s PROTECT 1 and PROTECT 2 studies which ...

  • Industries : Biopharmaceutical, Biotechnology, Pathology, Biological Therapy
  • Countries : Europe
Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • $ 1 995
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends ...

  • Industries : Biological Therapy, Drug Delivery Technology
  • Countries : World
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-recepto ...

  • Industries : Biological Therapy
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer

RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer

  • $ 1 125
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 92 RNA (miRNA, RNAi & siRNA) drugs known to affect more than 168 specific intracellular signaling pathways ...

  • Industries : Biological Therapy
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update

RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update

  • $ 2 243
  • Industry report
  • February 2016
  • by Bioseeker

Potentially any disease-causing gene, cell type or tissue can be targeted with miRNA, RNAi or siRNA, including those not ’druggable’ with small molecules or protein-based therapies. There are today ...

  • Industries : Biological Therapy
Nucleic Acid Therapies in Oncology Drug Pipeline Update

Nucleic Acid Therapies in Oncology Drug Pipeline Update

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Nucleic acid therapies in oncology includes: Gene Therapy, DNA vaccine, Other DNA technologies, RNA Interference (RNAi), Small interfering RNA (siRNA), Antisense RNA and Ribozymes. There are today 299 ...

  • Industries : Biological Therapy
MicroRNAs in Cancer Drug Pipeline Update

MicroRNAs in Cancer Drug Pipeline Update

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

The hot entry of microRNA (miRNA) targeting drugs in oncology may come to revolutionize how we in the near future can launch a highly tumor-specific, multi-targeted attack with minimal toxicities eithe ...

  • Industries : Biological Therapy
Melanoma Global Clinical Trials Review, H1, 2016

Melanoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • January 2016
  • by Global Data

Melanoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Melanoma Global Clinical Trials Review, H1, 2016" provides an overview of Melanoma clinical trials scenario. ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Sezary Syndrome Global Clinical Trials Review, H1, 2016

Sezary Syndrome Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • January 2016
  • by Global Data

Sezary Syndrome Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Sezary Syndrome clinical ...

  • Industries : Pathology
  • Countries : World
Ionis Pharmaceuticals, Inc. - Strategy and SWOT Report

Ionis Pharmaceuticals, Inc. - Strategy and SWOT Report

  • $ 175
  • Industry report
  • January 2016
  • by MarketLine

Introduction Ionis Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product ...

  • Industries : Pathology
  • Countries : United States
Translational Regenerative Medicine: Market Prospects 2016-2026

Translational Regenerative Medicine: Market Prospects 2016-2026

  • $ 2 623
  • Industry report
  • January 2016
  • by Visiongain

Report Details What can be expected from the Translational Regenerative Medicine market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, ...

  • Industries : Biological Therapy
  • Countries : World
Translational Regenerative Medicine: Market Prospects 2016-2026: Can Promising Therapies in Stem Cells, Tissue Engineering and Gene Therapy Change the Way We Treat Rare and Chronic Diseases?

Translational Regenerative Medicine: Market Prospects 2016-2026: Can Promising Therapies in Stem Cells, Tissue Engineering and Gene Therapy Change the Way We Treat Rare and Chronic Diseases?

  • $ 2 623
  • Industry report
  • January 2016
  • by Visiongain

Report Details What can be expected from the Translational Regenerative Medicine market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, ...

  • Industries : Biological Therapy
  • Countries : World
RNAi Technologies and Global Markets

RNAi Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2016
  • by BCC Research

This BCC Research report summarizes the global RNAi technologies market by category and by region. The RNAi market is analyzed based on RNAi research tools and reagents as well as on RNAi diagnostics. ...

  • Industries : Biological Therapy
  • Countries : World
Cell Analysis Market by Product, by Process, & by End User - Forecast to 2020

Cell Analysis Market by Product, by Process, & by End User - Forecast to 2020

  • $ 4 650
  • Industry report
  • January 2016
  • by MarketsandMarkets

The global cell analysis market is expected to reach USD 26.0 billion by 2020 from USD 19.0 billion in 2015, growing at a CAGR of 6.56% from 2015 to 2020. The global cell analysis market is categorized ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World, Europe, North America

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.